BOCIC(SH:601696) Xin Lang Cai Jing·2025-10-20 02:57Group 1 - The core point of the news is that Beijing Baipusi Biotechnology Co., Ltd. has seen a stock price increase of 5.34%, reaching 59.20 CNY per share, with a total market capitalization of 9.937 billion CNY as of October 20 [1] - The company was established on July 22, 2010, and went public on October 18, 2021, focusing on providing key biological reagent products and technical services, with main revenue sources being recombinant proteins (82.27%), antibodies and other reagents (12.88%), technical services (3.04%), and others (1.80%) [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Baipusi, with the Bank of China Health Industry Mixed Fund (002938) owning 99,000 shares, accounting for 4.48% of the fund's net value, making it the seventh-largest holding [2] - The Bank of China Health Industry Mixed Fund was established on September 7, 2016, with a current size of 158 million CNY, achieving a year-to-date return of 42.31% and a one-year return of 34.85% [2]